Results 141 to 150 of about 2,572,587 (193)

CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY

Juntendo Medical Journal, 2012
openaire   +2 more sources

Continuous Subcutaneous Insulin Infusion Therapy.

Journal of the Japan Diabetes Society, 1993
openaire   +1 more source

Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and Adolescents

Journal of Pediatrics, 2008
Objectives To describe the dermatological changes associated with continuous subcutaneous insulin infusion (CSII) therapy in youth with type 1 diabetes mellitus (T1D).
Louise S Conwell, Elena Pope, Alan Daneman   +2 more
exaly   +2 more sources

Continuous Subcutaneous Insulin Infusion in Diabetes: Patient Populations, Safety, Efficacy, and Pharmacoeconomics

Diabetes/Metabolism Research and Reviews, 2016
International audienceThe level of glycaemic control necessary to achieve optimal short-term and long-term outcomes in subjects with type 1 diabetes mellitus (T1DM) typically requires intensified insulin therapy using multiple daily injections or ...
Paolo Pozzilli, Tadej Battelino, Przemyslawa Jarosz-Chobot   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Continuous Subcutaneous Insulin Infusion in Children

Diabetic Medicine, 1987
Insulin‐dependent diabetes mellitus usually presents in childhood. Since it is generally accepted that persisting metabolic derangements contribute to the development of microand macrovascular complications, a primary aim of the management of children with diabetes is to achieve near normalization of metabolism.
DE BEAUFORT, Carine, Bruining, G. J.
openaire   +3 more sources

Continuous Subcutaneous Insulin Infusion or Subcutaneous Insulin Injections.

Lancet, The, 1979
T D R Hockaday, T D Hockaday, R C Turner
exaly   +2 more sources

Continuous Subcutaneous Insulin Infusions: Closing the Loop

The Journal of Clinical Endocrinology & Metabolism, 2022
AbstractContextContinuous subcutaneous insulin infusions (CSIIs) and continuous glucose monitors (CGMs) have revolutionized the management of diabetes mellitus (DM). Over the last 2 decades the development of advanced, small, and user-friendly technology has progressed substantially, essentially closing the loop in the fasting and postabsorptive state,
Carlos A Díaz-Balzac, David Pillinger, Steven D Wittlin   +2 more
openaire   +2 more sources

Continuous subcutaneous insulin infusion.

Diabetes care, 2002
Use of CSII requires care by skilled professionals, careful selection of patients, meticulous patient monitoring, and thorough patient education. Insulin pumps prescribed by a physician within these guidelines are a part of treatment and should be covered by the usual payment mechanisms.
openaire   +3 more sources